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Lymphatic vessels interact dynamically with the
hair follicle stem cell niche during skin
regeneration in vivo
Daniel Peña-Jimenez1,§, Silvia Fontenete1,2,§, Diego Megias3, Coral Fustero-Torre4,
Osvaldo Graña-Castro4, Donatello Castellana1,5, Robert Loewe6 & Mirna Perez-Moreno1,2,*
Abstract
Lymphatic vessels are essential for skin fluid homeostasis and
immune cell trafficking. Whether the lymphatic vasculature is
associated with hair follicle regeneration is, however, unknown.
Here, using steady and live imaging approaches in mouse skin,
we show that lymphatic vessels distribute to the anterior
permanent region of individual hair follicles, starting from
development through all cycle stages and interconnecting
neighboring follicles at the bulge level, in a stem cell-depen-
dent manner. Lymphatic vessels further connect hair follicles in
triads and dynamically flow across the skin. At the onset of
the physiological stem cell activation, or upon pharmacological
or genetic induction of hair follicle growth, lymphatic vessels
transiently expand their caliber suggesting an increased tissue
drainage capacity. Interestingly, the physiological caliber
increase is associated with a distinct gene expression correlated
with lymphatic vessel reorganization. Using mouse genetics, we
show that lymphatic vessel depletion blocks hair follicle growth.
Our findings point toward the lymphatic vasculature being
important for hair follicle development, cycling, and organiza-
tion, and define lymphatic vessels as stem cell niche compo-
nents, coordinating connections at tissue-level, thus provide
insight into their functional contribution to skin regeneration.
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Introduction
Lymphatic vessels (LV) play fundamental homeostatic functions
including the balanced transport of fluids and macromolecules,
the local coordination of immune responses, and immune cell
trafficking to regional lymph nodes (Skobe & Detmar, 2000). After
years of scientific discovery, much has been learned about the
distinctive characteristics of LV, including the molecular markers
prospero-related homeobox 1 (Prox1), lymphatic vessel endothe-
lial hyaluronan receptor 1 (LYVE1), and podoplanin, as well as
critical regulatory signals that govern their development and
fundamental functions in tissues (Wang & Oliver, 2010; Yang &
Oliver, 2014; Zheng et al, 2014; Potente & Makinen, 2017).
In skin, LV are organized in structured polygonal patterns,
consisting of one subcutaneous plexus, and a more superficial plexus
located in the dermis, near the blood vessels (Braverman, 1989).
Several studies have contributed to our understanding of the orderly
organization of LV in the skin (Skobe & Detmar, 2000; Tripp et al,
2008). These studies have provided insight into the existence of
branches of lymphatic capillaries that extend to the HF and drain
into the subcutaneous collecting LV, presumably through connec-
tions of blind capillaries with the dermal papillae (dp) (Forbes,
1938), a condensate of dermal fibroblasts that provides a specialized
microenvironment (Millar, 2002; Yang & Cotsarelis, 2010; Sennett &
Rendl, 2012). LV may also facilitate the entry of immune cells to
the HF epithelium, a source of chemokines that regulate the traf-
ficking of epidermal Langerhans cells and dermal dendritic cells
(Nagao et al, 2012), the distribution and differentiation of Langer-
hans cells (Wang et al, 2012), and the tropism of skin resident
memory T cells (Adachi et al, 2015). However, despite the role of
LV in facilitating immune cell trafficking to HF, less is known
about their coordinated connections during HF cycling and func-
tional implications.
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In adult skin, HF exhibits a lifetime polarized pattern of growth
and regeneration across the tissue modulated by stimulatory and
inhibitory signals (Plikus et al, 2011; Widelitz & Chuong, 2016).
The cyclic regeneration of HF involves phases of growth (Anagen)
via regression (Catagen) to relative quiescence (Telogen; Geyfman
et al, 2015). The entry of resting HF into Anagen requires the acti-
vation of HFSC located in the HF bulge (Cotsarelis et al, 1990;
Tumbar et al, 2004), and the expansion of their progenitors found
in the secondary hair germ, giving rise to a new Anagen HF
(Tumbar et al, 2004; Greco et al, 2009; Rompolas et al, 2012).
Anagen HF grows until other instructive signals promote their
regression giving rise to a new HF cycle. In past decades, a wealth
of knowledge has yielded valuable insight into the role of major
stimulatory and inhibitory signals in governing the orchestrated
activation of the HF cycle (Blanpain & Fuchs, 2009; Lee &
Tumbar, 2012; Plikus & Chuong, 2014), including local self-activa-
tion signals (Hsu et al, 2011), the contribution of other cells in
the tissue macroenvironment (Brownell et al, 2011; Festa et al,
2011; Castellana et al, 2014; Rivera-Gonzalez et al, 2016; Ali et al,
2017), and long-range signaling waves across the skin (Plikus
et al, 2011).
Blood vessels have also been found associated around HF
exhibiting a coordinated dynamic reorganization during HF
cycling (Mecklenburg et al, 2000; Yano et al, 2001). Also, HFSC
closely associates with a venule annulus (Xiao et al, 2013). The
occurrence of angiogenesis, the growth of new capillaries from
pre-existing blood vessels, has been observed during Anagen
(Mecklenburg et al, 2000). The epidermal expression of the
vascular endothelial growth factor A (VEGF-A; Detmar, 1996)
induces perifollicular angiogenesis and sustains HF growth;
conversely, inhibition of VEGF-A leads to a delay in HF growth
accompanied by reductions in HF size and perifollicular vascular-
ization (Yano et al, 2001). Overall, these results exposed that HF
and blood vessels form a functional operative system. In
contrast, less is known about the role of LV in regulating this
process. Here, we show that lymphatic capillaries are novel
components of the HFSC niche, coordinating HF connections at
tissue-level and provide insight into their functional association
to the HF cycle.
Results
Lymphatic capillaries distribute in the vicinity of HFSC in a
polarized manner
To investigate the association between LV and HFSC, we first
defined the lymphatic distribution at HF in mouse back skin. To
this end, we performed immunofluorescence analyses using anti-
bodies to the lymphatic marker LYVE1 as well as to alpha
smooth muscle actin (aSMA), enriched in the arrector pili muscle
(apm). Lymphatic capillaries distributed in a polarized manner,
aligned to the anterior side of the HF, opposite the distribution
described for the apm (Fujiwara et al, 2011), ascending as blind
capillaries along the HF permanent area toward the epidermis
until the infundibulum (Fig 1A). This distribution was different
from the one observed in the ear skin, which presented parallel
lymphatic capillaries that were not associated with HF
(Fig EV1A). In the back skin, lymphatic capillaries densely
distributed to the anterior side of HF at Tenascin-C areas
(Fig 1B), a glycoprotein of the extracellular matrix (ECM)
enriched in the HF bulge (Tumbar et al, 2004). To interrogate the
existence of a lymphatic association with both embryo and adult
HFSC, we next determined the lymphatic distance to Lhx2+ SC
(Fig 1C and D; Rhee et al, 2006) and CD34+ HFSC (Fig 1E and F;
Blanpain et al, 2004), respectively. Immunofluorescence analyses
of back skin sections of P5 and P12 mice (Fig 1C and D) and P49
mice (Fig 1E and F) revealed that lymphatic capillaries distributed
to the proximity of HFSC, within a distance inferior of 3 lm,
within the ratio expected for components of the HFSC niche
(Beck et al, 2011).
Next, we explored if functional HFSC creates a niche promoting
the continuous association of LV with the HF bulge. Wnt signaling
features prominently in HFSC and regulates their properties and
functional activity (Choi et al, 2013). Thus, we reduced the expres-
sion of Wnt ligands in HFSC by ablating the expression of Wls in
the Keratin 15 (K15) HFSC compartment, using the K15CrePR+/T;
WlsD/D conditional mouse model (Choi et al, 2013; Myung et al,
2013). Wntless (Wls) binds to Wnt ligands and controls their sorting
and secretion (Carpenter et al, 2010). Under these conditions, HFSC
remains quiescent, exhibiting a reduction in proliferation, but HF is
largely maintained (Choi et al, 2013; Myung et al, 2013). Consistent
with those findings, HF remained present in the skin (Fig 1G)
despite the loss of Wls, as confirmed by RT–qPCR analyses of
CD34+ a6 integrin+ FACS-isolated cells (Fig EV1B). LYVE1
immunofluorescence analyses revealed that the organized associa-
tion of LV with HF was disrupted, and LV were found distributed
parallel to the epidermis and distant from HF bulge areas (Fig 1G
and H), reminiscent to the organization of LV in the ear skin
(Fig EV1A). Overall, these results indicate that HFSC creates a niche
for lymphatic endothelial cells, and sustain a polarized pattern of
LV, which in turn, interconnect neighboring HF at the level of the
HF bulge across the skin.
Lymphatic capillaries start associating with HF
during morphogenesis
To gain further insight into the establishment of the LV–HF associ-
ation, we next turned to HF embryogenesis. HFSC emerges in the
early HF placode stage at E15.5, giving rise to the hair germ
(E16.5), hair pegs (E17.5), and embryo Anagen HF until the first
postnatal HF cycle. Whole mount immunofluorescence analyses of
LYVE1 at E15.5–E17.5 embryo stages (Fig 2A–C) revealed that
from E15.5, when HF placodes were already visible, nascent
networks of anastomosed LV start to form below areas of HF
growth. HF starts to develop via epithelial–mesenchymal inductive
signals stemming from the dermal papilla (dp) (Sennett & Rendl,
2012); however, no apparent lymphatic association with the dp
was observed at E15.5 or E16.5, and LV were rather aligned in
parallel to the epidermis, representative of lymphatic collecting
vessels (Fig 2A and B). Interestingly, at E17.5 upward grows of
lymphatic capillaries started to branch out from collecting vessels
toward the papillary dermis and distributed at HF sites (Fig 2C).
Overall, these results indicate that the development of HF is
coupled with the recruitment of lymphatic capillaries to HF sites,
likely subsequent to HF specification.
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Lymphatic vessels interconnect triads of HF across the back skin
To further analyze the organization of the lymphatic association
with HF, we conducted whole mount immunofluorescence anal-
yses of LYVE1 in adult skin sections (P70). This method
allowed discerning an additional arrangement level, where indi-
vidual LV–HF units associated further into triads (Fig 3A and
Movie EV1). The patterned polygonal organization of lymphatic-
HF domains across the skin was more evident in 3D projection
planes (Fig 3B and Movie EV2). Lymphatic capillaries were
found associated along the permanent portion of individual HF.
At the level of the HF bulge, lymphatic capillaries radiated and
converged interconnecting three HF units. These units presented
a common extending lymphatic capillary from each HF triad
(Fig 3B and Movie EV2). The mechanisms involved in the
lymphatic-HF patterning are interesting questions for the future,
but globally, these results uncharted the existence of coordi-
nated lymphatic arrays surrounding and interconnecting triads
of HF across the skin.
Lymphatic vessels continuously associate with the HF bulge
during the HF cycle
We next explored whether LV change their distribution to the HF
bulge areas during the postnatal HF cycle. These analyses were
performed in isolated back skin sections from matched skin areas at
defined stages of the HF cycle, including the postnatal HF morpho-
genesis (postnatal days 5–16, P5–P16), and the first (P23–P45) and
the second (P49–P85) HF cycle (Fig EV2; Muller-Rover et al, 2001).
The latter exhibits a more extended Telogen that lasts for
3–4 weeks; therefore, to perform our comparative analyses we
subdivided the second Telogen into early Telogen (Te, P49), mid-
Telogen (Tm, P55), late Telogen (Tl, P69), and included an Anagen
stage (AVI, P85; Muller-Rover et al, 2001). These phases corre-
sponded to the refractory and competent Telogen phases, as previ-
ously documented (Plikus et al, 2008).
Interestingly, at all HF stages, LV remained distributed in a polar-
ized manner, positioned at the anterior side of the permanent region
of the HF opposite to the apm, interconnecting neighboring HF at
the level of the HF bulge (Fig EV2A). The greater lymphatic density
was localized at the HF permanent region, exhibiting a significantly
higher area at postnatal HF morphogenesis stages (P5–P16;
Fig EV2B). Consistent with this distribution, the relative LV/HF
length increased from late Anagen stages to Telogen, when HF
mostly consists of the permanent region (Fig EV2C). Conversely,
this relative length was reduced during the transition from Telogen
to Anagen (Fig EV2C). Except for the HF stages P5, P12, and P16,
no changes in LV proliferation were observed (Fig EV2D), suggest-
ing that LV were still growing and reorganizing to developing HF.
Also, no changes in LV cell death were observed during the HF cycle
(Fig EV2E).
These studies exposed that LV establish a continuous connection
between neighboring HF at the level of the HF bulge across the skin
throughout all phases of the HF cycle.
Lymphatic vessels dynamically flow across triads of HF in the
back skin
To further pursue the existence of dynamic lymphatic flow
between neighboring HF triads across the skin, we analyzed the
lymphatic network by intravital microscopy, using a Prox1-
CreERT2; ROSA26-LSL-eYFP reporter mouse. This transgenic
mouse line expresses the tamoxifen-inducible Cre recombinase
(CreER) under the control of the Prox1 gene promoter (Bazigou
et al, 2011), under a Rosa26-LSL-eYPP background. Prox1 is
essential for LV development, and it is expressed throughout life,
providing lymphatic identity (Wigle & Oliver, 1999; Hong et al,
2002). These powerful tools allowed us to explore the dynamic
association of lymphatic capillary networks with HF in living skin
tissue. Our intravital microscopy analyses fully evidenced the
continuum-patterned organization of lymphatic networks around
HF in the back skin (Fig 3C). These analyses further allowed the
visualization of triads of HF interconnected by lymphatic capillar-
ies, aligned in parallel rows with an anterior to posterior disposi-
tion. Strikingly, the HF triads in each row interconnected with
neighboring parallel rows, mainly through a LV stemming from
one HF triad unit (Fig 3C), consistent with our prior observations
(Fig 3B and Movie EV2).
We next assessed whether LV dynamically streamed into the
continuum-patterned lymphatic networks around HF in the back
skin. To this end, TRITC–Dextran was administered in the mouse
back skin followed by intravital microscopy. These results allowed
◀ Figure 1. LV interact with HF in a functional HFSC niche-dependent manner.A Adult mouse back skin sections immunostained for LYVE1 (red), aSMA (green), and counterstained with DAPI (blue). n = 3–4 skin samples per mouse, n = 3–4 mice.
Scale bar, 50 lm. LV, lymphatic vessels; apm, arrector pili muscle.
B Back skin sections of P55 mouse skin immunostained for LYVE1 (red), Tenascin-C (green), and counterstained with DAPI (blue). n = 3–4 skin samples per mouse,
n = 3–4 mice. Scale bar, 50 lm. TNC, Tenascin-C.
C Adult mouse back skin sections from different postnatal (P) days immunostained for LYVE1 (red), Lhx2 (green), and counterstained with DAPI (blue). n = 3–4 skin
samples per mouse, n = 3–4 mice. Scale bar, 50 lm. epi, epidermis; der, dermis.
D Histogram of the quantification of the LV distance to HFSC positive for Lhx2. n = 3–4 skin samples per mouse, n = 3–4 mice. Data represent the mean value  SEM.
***P < 0.001 (Mann–Whitney U-test).
E Back skin sections of P49 mouse skin immunostained for LYVE1 (red), CD34 (green), and counterstained with DAPI (blue). n = 3–4 skin samples per mouse, n = 3–4
mice. Scale bar, 100 lm. epi, epidermis; der, dermis. White arrowheads denote the proximity of lymphatic capillaries to HFSC.
F Histogram of the quantification of the LV distance to HFSC positive for CD34. n = 3–4 skin samples per mouse, n = 3–4 mice. C, Catagen; Te, early Telogen; Tm, mid-
Telogen; Tl, late Telogen; A, Anagen. Data represent the mean value  SEM (Kruskal–Wallis test, Tukey’s test).
G Back skin sections of K15CrePR+/T; WlsD/D and Control K15CrePR+/+; Wlsflox/flox mice treated with mifepristone from P7 during 12 weeks (P90), immunostained for
LYVE1 (red), and counterstained with DAPI (blue). n = 3–4 skin samples per mouse, n = 3–4 mice. Scale bar, 100 lm. epi, epidermis; der, dermis.
H Histogram of the quantification of the LV angle relative to the epidermis. n = 3–4 skin samples per mouse, n = 3–4 mice. Data represent the mean value  SEM.
***P < 0.001 (Mann–Whitney U-test).
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the visualization of a continuous lymphatic flow interconnecting
adjacent HF rows (Movie EV3).
These results exposed the existence of a dynamic HF communi-
cation through lymphatic vascularization, which potentially facili-
tates the spreading of signaling waves and immune cell trafficking
across HF in the back skin.
Lymphatic endothelial cells transiently increase their caliber at
the onset of HF stem cell activation
Our previous findings raised the possibility that LV undergo dynamic
flow changes at different stages of the HF cycle. We investigated this
aspect by measuring the LV caliber in back skin sections during the
A B C
Figure 2. LV associate with HF during development.
A–C Distribution of LV and HF at the mouse embryo stage E15.5 (A), E16.5 (B), and E17.5 (C). Maximum projection images of whole mount immunofluorescence analyses
using LYVE1 (red) as lymphatic endothelial marker and counterstained with DAPI (blue). Red arrowheads denote HF placodes. n = 3–4 embryos. Scale bar, 50 lm.
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first and the second HF cycle, conducting LYVE1 immunofluores-
cence analyses. Intriguingly, the LV caliber was more pronounced at
the onset of the Telogen to Anagen transition (Fig 4A and B), with-
out exhibiting signs of proliferation or cell death (Fig EV2D and E).
We next inspected more closely the LV morphology and observed
that at late stages of Telogen, LV appeared more fenestrated
displaying membrane protrusions compared to the more continuous
and tight capillaries observed during Anagen. This structural varia-
tion, exhibiting a wide and irregular lumen, presumably accounts for
regional differences in capillary permeability (O’Driscoll, 1992) influ-
encing vascular exchange and increase tissue drainage capacity
(Aebischer et al, 2014; Betterman & Harvey, 2016).
A B
C
Figure 3. LV association with HF during the postnatal HF cycle.
A LV associated with individual HF further organize associating HF triads, which connect with other HF triads across the skin. P70, 70-day-old mice. n = 3–4 mice.
White arrowheads denote capillaries stemming from HF triads. Scale bar, 100 lm.
B 3D reconstructions of whole skin mounts showing a triad of HF connected by LV. n = 3–4 mice. Scale bar, 50 lm. White arrowhead denotes an extending lymphatic
capillary from a HF triad.
C Images of intravital microscopy analyses showing aligned HF rows in the back skin interconnected by LV in the Prox1CreERT2; Rosa-LSL-eYPF mice. Dotted boxes
denote HF triads; white arrowheads denote capillaries stemming from HF triads interconnecting to other HF triads in adjacent rows. n = 3–4 mice. Scale bar, 50 lm.
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We next explored whether the induction of HF growth induces
the transitory increase in the caliber of LV. To this end, to avoid
severing LV and the induction of an inflammatory response, we did
not conduct hair plucking experiments to synchronize HF, but
rather stimulated the Telogen to Anagen transition by reducing the
number of perifollicular macrophages at early Telogen with Clodro-
nate liposomes (Fig 4C–E), as previously described (Castellana
et al, 2014). Under these conditions, LV surrounding the precocious
Anagen HF displayed an increase in their caliber compared to
controls (Fig 4D and E). We further analyzed the connection
between HFSC cell proliferation and the expansion of LV caliber in
K14Cre+/T, DNb-cateninlox/lox mouse skin samples. This model is
characterized by continuous HFSC proliferation and pilomatricoma
formation (Lowry et al, 2005; Jensen et al, 2009). Immunofluores-
cence analyses for LYVE1 revealed a significant increase in LV
caliber under conditions of continuous HF growth (Fig 4F and G).
To interrogate whether a sustained increased in vascular flow
prompts the entry of Telogen HF into Anagen, we pharmacologi-
cally treated mice in early Telogen (P49) with Cilostazol (Kimura
et al, 2014); as previously documented (Choi et al, 2018), increas-
ing the vascular flow led to precocious HF growth and an increase
in the percentage of HF in Anagen (Fig 4H). Overall, these results
exposed the existence of networks of LV that dynamically reorga-
nize increasing their caliber upon activation of HFSC.
Transcriptome analysis of lymphatic endothelial cells at the
onset of HFSC activation
Our prior results prompted us to analyze the existence of a differen-
tial gene expression in LV during the physiological HF Telogen to
Anagen transition, when LV exhibit an expanded caliber (Fig 4A and
B). We focused on the physiological Tm (P55) and Tl (P70) phases of
the second HF cycle as HF progress to Anagen. To this end, we
FACS-isolated eYFP+ dermal LV from the back skin of Prox1-
CreERT2+/T; Rosa26-LSL-eYFPKI/KI mice, where 60% of the cells
represent lymphatic endothelial cells (Bianchi et al, 2015). We
avoided including the dermal subcutaneous collector LV, through
mechanical removal before tissue digestion. To comprehensively
define changes in the molecular traits of isolated cells, we conducted
RNA sequencing (RNA-seq) analyses. The transcriptome profiles
revealed the expression of genes differentially regulated between the
analyzed populations. We first determined the existence of differen-
tially expressed pathways in Tl compared with Tm phases,
establishing LV gene expression rankings using gene set enrichment
analyses (GSEA) compared with public annotations from Reactome,
BioCarta, Kyoto Encyclopedia of Genes and Genomes (KEGG), and
Gene Ontology (GO) databases. The majority of the differentially
regulated genes (FDR q-values < 0.25) were related to cell adhesion,
cytoskeleton, and lymphatic organization/axon guidance (Fig 5A).
Further analyses revealed that 310 genes were upregulated and 562
downregulated with a 2.8-fold change (log2 fold change > 1.5 or
< 1.5) at Tl (P70) compared with Tm (P55). Enrichr analyses (Chen
et al, 2013; Kuleshov et al, 2016) were then used to classify the
major represented categories, which exposed the differential expres-
sion of genes related to LV remodeling (Fig 5B and C), in agreement
with the transitory morphological changes observed in LV at the
onset of HFSC activation. The genes encoded proteins involved in
ECM, cytoskeleton and adhesion processes, lymphatic remodeling
and axon guidance as well as genes involved in intracellular signal-
ing processes. Some transcripts of the most over-represented path-
ways were validated by double in situ hybridization analyses for
LYVE1 and candidate transcripts (Figs 5D–G and EV3A–D), or by
double immunofluorescence analyses (Figs 5H and I, and EV3E and
F). Transcripts encoding the ECM adhesion protein integrin a5
(ITG5A) were found upregulated (Figs 5D and EV3A) at Tl (P70)
compared with Tm (P55), while the ECM secreted proteoglycan
decorin (DCN) levels tended to be downregulated although non-
significant (Figs 5E and EV3B). Also, an increased immunofluores-
cence intensity for the adhesion protein Jup was observed in the
expanded and irregular LV lumen surrounding HF at P70 compared
with P55 (Figs 5H and EV3E). The expression of transcripts encoding
for the lymphatic remodeling and axon guidance proteins Polycystin-
1 (PKD1; Figs 5F and EV3C), Plexin D1 (PLXND1; Figs 5G and
EV3D), and the immunofluorescence intensity of Emilin1 (Figs 5I
and EV3F) was also found upregulated at Tl (P70) compared with
Tm (P55).
These genes have been involved in the regulation of lymphatic
remodeling, lumen organization, and permeability, and taken
together, these results support the existence of a transitory dynamic
reorganization of LV at the onset of HFSC activation.
Depletion of LV blocks both the pharmacological induction and
the physiological HF growth
To get insight into the functional association between LV and the
HF cycle, we pharmacologically stimulated HF growth, followed by
◀ Figure 4. Dynamic reorganization of LV during the HF cycle.A Adult back skin sections from different postnatal (P) days immunostained for LYVE1 (red) and counterstained with DAPI (blue). n = 3–4 skin samples per mouse,
n = 3–4 mice. Scale bar, 10 lm. White arrowheads denote LV membrane protrusion and fenestrated areas. LV, lymphatic vessels; HF, hair follicle.
B Histogram of the caliber (lm) of LV at different postnatal days. n = 3–4 skin samples per mouse, n = 3–4 mice. A, Anagen; C, Catagen; T, Telogen; Te, early Telogen;
Tm, mid-Telogen; Tl, late Telogen. The data shown represent the mean value  SEM. *P < 0.05; **P < 0.01; ***P < 0.001 (one-way ANOVA, Tukey’s test).
C H&E staining of back skin sections from mice treated intradermally with Control or Clodronate liposomes. n = 3–4 skin samples per mouse, n = 3–4 mice. Scale
bar, 200 lm. epi, epidermis; der, dermis.
D, E LYVE1 immunofluorescence (red) counterstained with DAPI (blue) (D) and histogram of the caliber (lm) of LV (E) in back skin sections from mice treated
intradermally with Control or Clodronate liposomes. n = 3–4 skin samples per mouse, n = 3–4 mice. Scale bar, 100 lm. epi, epidermis; der, dermis. The data shown
represent the mean value  SEM. ****P < 0.0001 (Mann–Whitney U-test).
F Back skin sections of Controls and K14DNb-cateninER+/T mice immunostained for LYVE1 (red) and counterstained with DAPI (blue). n = 3–4 skin samples per
mouse, n = 3–4 mice. Scale bar, 50 lm. epi, epidermis; der, dermis.
G Histogram of the LV caliber in skin sections from Controls and K14DNb-cateninER+/T mice. n = 3–4 skin samples per mouse, n = 3–4 mice. Data represent the
mean value  SEM. ****P < 0.0001 (Mann–Whitney U-test).
H Histogram of the percentage of HF in Telogen and Anagen present in the skin of control mice or mice treated with Cilostazol. n = 3–4 skin samples per mouse,
n = 3–4 mice. Data represent the mean value  SEM. *P < 0.05; **P < 0.01 (Mann–Whitney U-test).
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loss of function approaches using the mouse genetic model Prox1-
CreERT2+/T;Rosa26-LSL-iDTRKI/KI mice to conditionally ablate LV.
Prox1CreERT2+/T;Rosa26-LSL-iDTRKI/KI and controls were first
treated at early Telogen (P49) with cyclosporine A (CSA), a potent
hair growth stimulator (Paus et al, 1989; Gafter-Gvili et al, 2003;
Horsley et al, 2008), which activates quiescent HFSC through the
A
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inhibition of calcineurin and the transcription factor of activated T
cells c1 (NFATc1; Gafter-Gvili et al, 2003; Horsley et al, 2008).
Consistent with those prior findings, the precocious growth of HF in
CSA-treated mice was fully distinctive at the end of the experiment
compared to controls, as observed by histological approaches
(Fig 6A and B). Precocious HF exhibited a significant increase in
proliferation, as evidenced by immunohistological analyses of the
proliferation marker Ki67 (Fig 6C and D). Moreover, in agreement
with our prior findings (Fig 4), the induction of precocious HF
growth promoted a significant increase in LV caliber (Fig 6E and
F).
CSA-treated Prox1CreERT2-iDTR mice were further treated with
intradermal injections of diphtheria toxin (DT) for 3 days before the
end of the CSA treatment. The DT treatment leads to a significant
ablation of LV, as confirmed by reductions in lymphatic drainage,
supported by the impairment of Evans Blue dye clearance in skin
(Fig EV4A) and LYVE1 immunofluorescence analyses (Fig EV4B).
Strikingly, the loss of LV precluded the precocious activation of HF
growth induced by CSA, as evidenced by histological features
(Fig 6A and B) and a significant reduction of Ki67+ proliferating
cells (Fig 6C and D), in comparison with CSA-treated controls. As
an additional control, we also included Prox1CreERT2+/T; Rosa26-
LSL-iDTRKI/KI mice at early Telogen that were not treated with CSA,
and no changes in HF organization of growth were observed upon
LV ablation with DT (Fig EV5A and B). To further analyze the impli-
cations of LV in supporting HF growth, we ablated LV with DT for
3 days during the physiological Anagen of the first HF cycle
(Fig 6G–J). The results show that the ablation of LV (Fig EV5C)
prompted to a collapse of growing HF (Fig 6G and H), accompanied
with cell death (Fig 6I and J) and loss of the growing HF differenti-
ated layers (Fig EV5C–F).
These results exposed a functional connection between LV and
HF growth.
Discussion
Mammalian HF undergoes a lifetime cyclic regeneration, and several
discoveries have increased our understanding on the regulation of
this significant model of organ regeneration, both at individual HF
level, through coordinated interactions with other cells at the HFSC
niche or molecular signaling across adjacent HF across the tissue
(Widelitz & Chuong, 2016; Gonzales & Fuchs, 2017; Guasch, 2017).
Here, we now show that within a single HF, HFSC associates with
LV capillaries, starting from developmental HF stages. We further
uncovered the existence of a dynamic patterned association of LV
with adjacent HF across the skin and defined that the loss of LV
abrogates the pharmacological induction of HF regeneration. These
findings position LV as new elements of the HFSC niche and open
new interesting questions about the potential roles of LV in regulat-
ing individual and adjacent HF at different stages of the physiologi-
cal HF cycle.
We first discovered that the interaction of LV with individual HF
is polarized and occurs along the anterior permanent HF region
(Fig 1). Of note, we did not observe a preferential association of LV
with particular HF types, as it has been observed for mechanosen-
sory neurons (Li et al, 2011). It remains to be investigated whether
the polarized LV–HF association is dependent on the existence of
differentially expressed molecules at the anterior/posterior sides of
the HF, thereby creating a distinct connection similar to the one
documented between HF and the apm (Fujiwara et al, 2011). The
nature of the lymphatic endothelial cells associated with HF is also
intriguing, since they are plastic and heterogeneous among organs
(Jang et al, 2013; Martinez-Corral et al, 2015; Petrova & Koh, 2018).
Thus, a defined population may exert specific functions at HF,
compared to lymphatic endothelial cells distributing at other
anatomical locations within the skin.
It is generally well-acknowledged that HFSC creates a special
niche microenvironment, where the interactions with other cells
within the niche are important for HFSC organization and function
(Gonzales & Fuchs, 2017; Guasch, 2017). In this regard, we
observed that a functional HFSC niche is required to sustain the
polarized LV–HF association in the back skin, through the expres-
sion of Wnt ligands. In the absence of HFSC-derived Wnts, LV disso-
ciate from HF allocating parallel to the epidermis (Fig 1G and H), in
a similar disposition to the one observed in the ear skin (Fig EV1A),
supporting the existence of unique LV regional microenvironments.
Interestingly, the lymphatic capillaries that associate with individual
HF further branch at the level of HFSC, converging into a single LV
for every three HF units, which in turn interconnect with other HF
triads across the skin (Fig 3). This patterned LV organization resem-
bles the one documented for dermal blood vessels distributed at the
dermal plexus (Sada et al, 2016). At this location, blood vessels set
different regional areas and contribute to the maintenance of two
independent epidermal stem cell populations. However, respecting
HFSC, blood vessels are distributed in a distinct manner, forming a
venule annulus starting from morphogenesis (Xiao et al, 2013). It
remains to be explored whether LV exert a defined regulatory role
on a particular SC population, since distinct populations of SC
exhibiting different potential arise from morphogenesis to later
◀ Figure 5. Transcriptome analysis of LV in late Telogen compared with mid-Telogen.A Gene set enrichment plots (GSEA) of LV using public annotations showing the enrichment of selected gene signatures involved in different pathways in late
Telogen (P69, Tl) compared with mid-Telogen (P55, Tm). NES: normalized enrichment score. The false discovery rate (FDR; q-value) is indicated.
B Table of differentially expressed genes (DEGs), in LV during late Telogen compared to mid-Telogen, relative to biological processes, analyzed using the Enrichr
platform (Chen et al, 2013; Kuleshov et al, 2016). Upregulated (red) and downregulated (blue). Data shown represent the fold change of the genes.
C Heatmap diagram of DEGs in LV during late Telogen compared with mid-Telogen, relative to biological processes, analyzed using the Enrichr platform (Chen et al,
2013; Kuleshov et al, 2016). Data shown represent the log2 (FPKM + 1).
D–G Histograms of RNA ISH analyses by RNAscope to quantify the level of expression of ITGA5 (D), DCN (E), PKD1 (F), and PLXND1 (G), assessed by the number of mRNA
spots present in LYVE1+ cells in the vicinity of HF in P55 and P70 mouse back skin. n = average of 30 LYVE1+ cells/sample, n = 3 mice. Data represent the mean
value  SEM. *P < 0.05; **P < 0.01 (D, F, and G, unpaired Student’s t-test; E, Mann–Whitney U-test).
H, I Histograms represent the mean fluorescence intensity for Jup (H) and Emilin1 (I) in LYVE1+ cells in the vicinity of HF in P55 and P70 mouse back skin. n = 3–4 skin
samples per mouse, n = 3–4 mice. Data represent the mean value  SEM. **P < 0.01, ***P < 0.001 (H, Mann–Whitney U-test; I, unpaired Student’s t-test).
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localize along the HF permanent region and at the HF bulge
(Guasch, 2017). The LV connection with developing HF from
embryo stages likely occurs after HF specification (Fig 2). This asso-
ciation could potentially implicate that LV regulate specific popula-
tions of SC after their specification favoring the subsequent HF
development by regulatory signals, or through facilitating the access
to nutrients or immune cell trafficking to the developing HF.
In adult skin, we observed that LV dynamically flow through
neighboring HF across the skin. Interestingly, the LV caliber tran-
siently expanded at the onset of HFSC activation (Fig 4), suggesting
an increased tissue drainage capacity. Studies combining live imag-
ing approaches and biophysical analyses of LV will be instrumental
for defining spatiotemporal changes in LV dynamics at different
stages of the HF cycle. The dynamic flow of LV through HF likely
facilitates the distribution of molecules and immune cells across the
skin. Although it remains unclear whether changes in the diffusion
of soluble or cellular components through LV is linked to HF cycle
regulation, our results now add LV as new roads connecting HF
across the skin and pave the way for further investigation. In this
regard, it is well acknowledged that the coordinated propagation of
stimulatory/inhibitory signals across the skin regulates the HF cycle
(Widelitz & Chuong, 2016). Interestingly, measurements of the
decline levels of diffusible molecules, including growth factors,
morphogens, and cytokines, predicted that their range of action is
restricted to no more than 100 lm (Teleman & Cohen, 2000; Weber
et al, 2013). However, in the back skin it has been observed that the
effect of diffusible molecules is exerted at more than 1 mm further
from their initial expression site (Chen et al, 2015). Thus, LV could
potentially partake in this event aiding the diffusion of molecules at
longer distances. Also, LV functional roles in draining tissue fluids
could further modulate the concentration level of molecular inhibi-
tors or activators at specific phases of the HF cycle.
LV may also regulate immune cell trafficking to HF areas,
although immune privilege areas are normally devoid of LV (Paus
et al, 2003). Indeed, it has been recently reported that Foxp3+ T
regulatory cells, which traffic through LV (Hunter et al, 2016), local-
ize to HF, and regulate HFSC proliferation (Ali et al, 2017). Perifol-
licular macrophages have also been shown to contribute to the
activation of HFSC through the expression of Wnt ligands
(Castellana et al, 2014), and myeloid Wnt ligands regulate the
development of LV (Muley et al, 2017). Moreover, macrophages
regulate LV caliber (Gordon et al, 2010), through the expression of
Wnt ligands (Muley et al, 2017). Interestingly, our observations on
the transient increment of the LV caliber at the onset of HFSC activa-
tion also coincide with the documented expression of macrophage-
derived Wnt ligands and the activation of HFSC (Castellana et al,
2014). Thus, changes in the LV caliber could exert regulatory func-
tions through the spatiotemporal diffusion of morphogens and the
influx and outflow of immune cells to HF at specific phases of the
HF cycle.
Our results exposed a marked increase in the LV caliber during
the physiological late Telogen to Anagen transition (Fig 4). The
induction of HFSC activation by modulating macrophage levels or
upon pharmacological induction with CSA (Figs 4 and 6) exposed
a functional connection between HFSC and LV caliber expansion
upon HFSC activation. These changes were sustained under condi-
tions of continuous HF growth as observed in the skin of
K14Cre+/T, DNb-cateninlox/lox mice (Fig 4). During the physiologi-
cal Telogen to Anagen transition, these LV changes were associ-
ated with a more irregular and fenestrated lumen morphology, in
agreement with the distinct expression of genes encoding proteins
mainly involved in lymphatic cytoskeletal remodeling and matrix
cell adhesion (Fig 5A and B), suggesting the occurrence of
mechanotransduction processes, changes in interstitial pressure,
and modulation of tissue drainage (Planas-Paz & Lammert, 2013;
Sabine et al, 2016). Whether these modifications could also lead
to changes in the HFSC niche stiffness, which are known to regu-
late HFSC behavior (Lane et al, 2014), needs further investigation.
The physiological roles of the identified LV signatures, as well as
their potential roles in the activation/inhibition of HF regeneration
as direct/indirect effectors, remain to be explored. To gain insight
into the functional connection of LV in the regulation of HF
behavior, we conditionally depleted LV upon the pharmacological
induction of HFSC activation and during the physiological HF
growth. These analyses exposed a functional connection between
LV and HF growth (Fig 6).
In future studies, it will be important to analyze the contributions
of LV along the different stages of the physiological HF cycle as well
◀ Figure 6. Depletion of LV blocks both the pharmacological induction and the physiological HF growth.A, B H&E staining (A) and histogram of the HF length (B) in adult back skin sections from Prox1CreERT2+/+; LSL-ROSA26-iDTRKI/KI mice injected with vehicles (Control),
Prox1CreERT2+/T; LSL-ROSA26-iDTRKI/KI mice treated with CSA and vehicle (CSA); and Prox1CreERT2+/T; LSL-ROSA26-iDTRKI/KI treated with tamoxifen, CSA, and
intradermal diphtheria toxin (CSA + DT) starting from early Telogen (P49) and analyzed at the end of the treatments (P58). n = 3–4 skin samples per mouse,
n = 3–4 mice. Scale bar, 200 lm. Data represent the mean value  SEM. ****P < 0.0001 (one-way ANOVA, Tukey’s test).
C, D Ki67 immunostaining (C) and histogram of the number of Ki67+ cells per HF (D) in adult back skin sections from Prox1CreERT2+/+; LSL-ROSA26-iDTRKI/KI mice
injected with vehicles (Control), Prox1CreERT2+/T; LSL-ROSA26-iDTRKI/KI mice treated with CSA and vehicle; and Prox1CreERT2+/T; LSL-ROSA26-iDTRKI/KI treated with
tamoxifen, CSA, and intradermal DT, starting from early Telogen (P49) and analyzed at the end of the treatments (P58). n = 3–4 skin samples per mouse, n = 3–4
mice. Scale bar, 20 lm. Data represent the mean value  SEM. ****P < 0.0001 (one-way ANOVA, Tukey’s test).
E, F LYVE1 immunostaining (E) and histogram of the LV caliber (F) analyzed in adult back skin sections from Prox1CreERT2+/+; LSL-ROSA26-iDTRKI/KI mice injected with
vehicles (Control), Prox1CreERT2+/T; LSL-ROSA26-iDTRKI/KI mice treated with CSA and vehicle (CSA); and Prox1CreERT2+/T; LSL-ROSA26-iDTRKI/KI mice treated with
tamoxifen, CSA, and intradermal DT, starting from early Telogen (P49) and analyzed at the end of the treatments (P58). Scale bar, 10 lm. n = 3–4 skin samples per
mouse, n = 3–4 mice. Data represent the mean value  SEM. ***P < 0.001 (Mann–Whitney U-test).
G, H H&E staining (G) and histogram of the HF length (H) in adult back skin sections from Prox1CreERT2+/+; LSL-ROSA26-iDTRKI/KI mice (Control) and Prox1CreERT2+/T;
LSL-ROSA26-iDTRKI/KI mice treated with tamoxifen and intradermal DT, starting from Anagen (P30) and analyzed at the end of the treatments (P37). n = 3–4 skin
samples per mouse, n = 3–4 mice. Scale bar, 200 lm. Data represent the mean value  SEM. ****P < 0.0001 (unpaired Student’s t-test).
I, J Cleaved caspase-3 immunostaining (I) and histogram of the number of cleaved caspase-3+ cells per HF (J) in adult back skin sections from Prox1CreERT2+/+; LSL-
ROSA26-iDTRKI/KI mice (Control) and Prox1CreERT2+/T; LSL-ROSA26-iDTRKI/KI mice treated with tamoxifen and intradermal DT, starting from Anagen (P30) and
analyzed at the end of the treatments (P37). Scale bar, 50 lm. n = 3–4 skin samples per mouse, n = 3–4 mice. Data represent the mean value  SEM.
****P < 0.0001 (Mann–Whitney U-test).
12 of 17 The EMBO Journal 38: e101688 | 2019 ª The Authors
The EMBO Journal Daniel Peña-Jimenez et al
as in other specific HF stages. The study of the contribution of LV at
defined HF stages, along with the study of signals arising from
HFSC, is particularly relevant, since the temporal diffusion of activa-
tors or inhibitors must likely lead to different responses in HF
cycling in a spatiotemporal manner. Clinically, it would be relevant
to expand these analyses to a human setting. Taken together, our
results position LV as novel components of the HFSC niche coordi-
nating HF connections at tissue-level and provide insight into their
functional association to the HF cycle.
Materials and Methods
Mice and treatments
All mouse experiments were approved and performed according to
international, institutional, and ethical regulations, with the
approval of the local authorities.
Back skins from C57Bl/6 mice (n = 3–5) from different embry-
onic (E15.5, E16.6, and E17.5) and postnatal (P) days (P5, P12, P16,
P23, P35, P45, P49, P55, P69, and P85) were collected to analyze
different phases of the HF cycle.
The Prox1-CreERT2 mouse model (Tg(Prox1-cre/ERT2)#aTmak,
a kind gift from Dr. Taija Ma¨kinen, Uppsala University; Bazigou
et al, 2011), was crossed under the background of the ROSA26-LSL-
eYFP reporter mice. The eYFP expression was induced by intraperi-
toneal injections of 2 mg Tamoxifen (T5648, Sigma-Aldrich) in
sunflower oil for 4 days.
Skin resident macrophages were reduced by treating P49 mice
with intradermal injections of 1 mg of Clodronate encapsulated lipo-
somes or empty liposomes as controls (Encapsula NanoSciences), as
described previously (Castellana et al, 2014).
Cilostazol treatments were carried out by treating P49 mice with
intradermal injections of 100 lg Cilostazol or vehicle control every
2 days for 9 days before sacrifice.
The Prox1-CreERT2; ROSA26-LSL-iDTR (Gt(ROSA)26Sortm1
(HBEGF)Awai/J, Jackson) mice were used to ablate LV. Mice were
treated with 1 ng/g diphtheria toxin (DT) (322326, Calbiochem) via
intradermal injections for 3 days. To assess LV ablation, at the end
of experiments mice were intradermally injected with 10 ll of 1%
Evans blue dye (E2129, Sigma-Aldrich). Skin samples were collected
16 h later and incubated in formamide (F9037, Sigma-Aldrich) at
55° for 24 h to extract the dye from the tissue. The dye levels were
quantified by measuring the absorbance of the dye at 610 nm.
To analyze the effect of LV ablation upon induction of HF growth,
mice were treated with the intraperitoneal administration of 100 mg/kg
Cyclosporin A (CSA, 30024, Sigma-Aldrich) during 10 days starting at
P49. At P52, mice were injected intraperitoneally with 2 mg Tamox-
ifen in sunflower oil for 4 days to induce the expression of the DT
receptor (iDTR), followed by the intradermal administration of DT for
3 days starting at P56 before sacrifice at P58.
To ablate LV during the physiological HF Telogen, P49 mice were
injected intraperitoneally with Tamoxifen for 4 days, followed by
the intradermal administration of DT for 3 days starting at P53
before sacrifice at P55. For LV ablation during the Anagen phase of
the first HF cycle, P30 mice were injected intraperitoneally with
Tamoxifen for 4 days, followed by the intradermal administration of
DT for 3 days starting at P34 before sacrifice at P37.
K15-CrePR1 mice [(Krt1-15-cre/PGR)22Cot/J] (Morris et al,
2004) and Wlstm1.1Lan/J mice (Carpenter et al, 2010) were acquired
from Jackson Labs. K15-CrPR1+/T/; Wlslox/lox 7-day-old mice were
then treated with Mifepristone (#M8046, Sigma-Aldrich) adminis-
tered in the drinking water at 429 ng/ml (Babij et al, 2003) to the
mother females and continued in weaned mice until the end of the
experiment (12 weeks of treatment). K14DNb-cateninER-transgenic
mouse back skin samples were kindly provided by Dr. Kim Jensen
(Biotech Research and Innovation Centre—BRIC, University of
Copenhagen; Jensen et al, 2009).
Immunofluorescence
Back skin samples were embedded in paraffin blocks and optimal
cutting temperature (OCT) compound. Paraffin sections were rehy-
drated and treated for antigen retrieval using 10 mM sodium citrate,
0.05% Tween 20, pH 6.0 at 100°C for 10 min. Slides were incubated
in blocking buffer: 0.3% Triton X-100–PBS (PBST), 5% FBS (F7524,
Sigma-Aldrich), 1% gelatin from cold water fish skin (G7765,
Sigma-Aldrich), and 1% BSA (10 735 078 001, Roche). Primary anti-
bodies (Appendix Table S1) were diluted in blocking buffer and
incubated overnight at 4°C and washed. The slides were then incu-
bated for 1 h with the corresponding secondary antibodies
(Appendix Table S2) and counterstained with DAPI. For OCT
sections, samples were fixed in 4% PFA for 10 min and the antibody
stainings were performed as described for paraffin-embedded
sections.
For whole mounts and tissue clearing, embryo and postnatal
back skins were fixed overnight in 4% PFA (15710, Electron
Microscopy Sciences) at 4°C. The back skins were cut into small
pieces, washed 10 times in PBST for 30 min each, and incubated
with primary antibodies diluted in Blocking Buffer (0.3% PBST,
5% FBS and 20% DMSO) at room temperature during 5 days.
Back skins were washed in PBST as previously described, followed
by their incubation with secondary antibodies and counterstained
with DAPI for 3 days at room temperature. Tissues were dehy-
drated in increasing concentrations of methanol (25, 50, and 75%
methanol for 5 min) and placed in 100% methanol three times
20 min each. Next, back skins were cleared overnight in 1:2
benzyl alcohol: benzyl benzoate (BABB) (B6630 and 402834,
Sigma-Aldrich).
Images were acquired in a TCS-SP5 (AOBS) confocal (Leica
microsystems) microscope. High-resolution images were captured
using a 63× HCX PL APO 1.3 Glycerol immersion objective.
The quantitative analyses of fluorescence intensity were
performed as previously described (Verma et al, 2012). Briefly,
regions of interest were plotted in LYVE1+ cells in the vicinity of HF
throughout skin sections and used to evaluate the mean fluores-
cence intensity of Jup and Emilin1 using ImageJ.
Intravital confocal microscopy
Mice were anesthetized with 1.5% isoflurane and placed into a
custom-made adapter with a stable temperature during the whole
duration of the experiments. Intravital experiments were carried out
in a TCS-SP5 (AOBS) confocal (Leica microsystems). The image
acquisition was conducted during 8 h every 15 min, using a 20×
HCXPL APO 0.7 N.A. dry objective.
ª The Authors The EMBO Journal 38: e101688 | 2019 13 of 17
Daniel Peña-Jimenez et al The EMBO Journal
FACS and RNA extraction
Back skins of Prox1-CreERT2; ROSA26-LSL-eYFP mice were
collected the day after the last intraperitoneal injection of 2 mg
Tamoxifen. Next, the subcutaneous fat was removed with a scalpel,
and the skin samples were cut into small pieces and incubated in
0.33 mg/ml of Liberase TM Research Grade (05401119001, Roche)
at 37°C for 30 min. After incubation, skin samples were transferred
to a MACS gentle dissociator C tube (130-093-237, Miltenyi Biotec)
and filtered through 40- and 70-lm cell strainers (352350 and
352340, Falcon). Red blood cells were eliminated with lysing buffer
(555899, BD Biosciences). DAPI was added as a viability dye, and
FACS-isolated eYFP-positive cells (FACS ARIA IIu sorter, Becton
Dickinson) were collected in Lysis Buffer (400753, Absolutely RNA
Nanoprep Kit, Agilent Technologies).
For the analysis of the expression of Wls in HFSC, HFSC was
FACS isolated and stained as previously described using the markers
CD34 and a6 integrin (Castellana et al, 2014). RNA extraction was
performed following manufacturer’s instructions.
RNA isolation and real-time PCR (RT–PCR)
1 lg of total RNA isolated from skin using TRIzol (15596026, Invit-
rogen) was used for cDNA synthesis using the Ready-to-Go You-
Prime It First-Strand beads and random primers (GE Healthcare).
RT–PCRs were conducted using the GoTaq qPCR Master Mix
(A6001, Promega) and a MasterCycler Ep-Realplex thermal cycler
(Eppendorf).
The expression levels were normalized to Actin. The complete
list of primers used is presented in Appendix Table S3.
RNA sequencing
Variable amounts of total RNA samples, between 50 and 2,000 pg,
were processed with the SMART-Seq v4 Ultra Low Input RNA Kit
(Clontech) by following manufacturer instructions. Resulting cDNA
was sheared on an S220 Focused-ultrasonicator (Covaris) and
subsequently processed with the “NEBNext Ultra II DNA Library
Prep Kit for Illumina” (NEB #E7645). Briefly, oligo(dT)-primed
reverse transcription was performed in the presence of a template-
switching oligonucleotide; double-stranded cDNA was produced by
limited-cycle PCR and submitted to acoustic shearing. Fragments
were processed through subsequent enzymatic treatments of end-
repair, dA-tailing, and ligation to Illumina adapters. Adapter-ligated
libraries were completed by six cycles of PCR. Reads were
sequenced in single-end mode (51 bp) on an Illumina HiSeq2500 by
following manufacturer’s protocols.
Gene expression analysis by RNA-seq and Gene set
enrichment analysis (GSEA)
The differential expression of genes was assessed using the
Nextpresso pipeline (http://bioinfo.cnio.es/nextpresso/). The
sequencing quality was analyzed with FastQC (http://www.b
ioinformatics.babraham.ac.uk/projects/fastqc/); reads were
aligned to the mouse genome (GRCm38/mm10) using TopHat-
2.0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al,
2009), and Samtools 0.1.19.0 (Li et al, 2009). The assembly of
transcripts, abundance estimation, and differential expression
were calculated with Cufflinks 2.2.1 (Trapnell et al, 2012),
using the mouse GRCm38/mm10 transcript annotations from
https://ccb.jhu.edu/software/tophat/igenomes.shtml. We then
used the RNA-seq gene list, where genes were ranked according
to their statistical expression difference to perform a GSEAPrer-
anked analysis (Subramanian et al, 2005), using pathway
annotations from Reactome, BioCarta, NCI (http://www.ndexbio.org/
#/user/301a91c6-a37b-11e4-bda0-000c29202374), and KEGG public
databases.
All basic and advanced fields were set to default, and we consid-
ered only the gene sets with false discovery rate (FDR)
q-values < 0.25 that were significantly enriched.
For enrichment analysis, genes with a variation of log2 fold change
> 1.5 or < 1.5 were selected and introduced in the Enrichr tool
(Chen et al, 2013; Kuleshov et al, 2016). The genes that belonged to
the categories of interest were chosen for the heatmaps. Heatmaps
representing the log2(FPKM + 1) levels were done using the software
Morpheus (https://software.broadinstitute.org/morpheus).
In situ hybridization
Double in situ hybridization (ISH) (RNAscope 2.5 HD Duplex Assay
Kit (ACD, 322440), Advanced Cell Diagnostics, Hayward, CA) was
performed in P55 and P70 mouse back skin. LYVE1 was used as a
lymphatic marker [Advanced Cell Diagnostics (ACD) Probe:
428451]. The expression of the following genes in LYVE1+ lymphat-
ics was analyzed as follows: ITGA5 (ACD Probe:575741), PKD1
(ACD Probe:549151), PLXND1 (ACD Probe:405931), or DCN (ACD
Probe:13179).
Positive staining was indicated by red and blue punctate mRNA
spots present in the nucleus and/or cytoplasm. The quantitative
analyses are represented as mean of the number of mRNA spots per
LYVE1+ cells in the vicinity of HF throughout skin sections.
Statistical analyses
Image analyses were performed using ImageJ and Imaris software
(Bitplane Scientific Software, Zurich). For statistical analysis of
quantitative data, the normality of the data was evaluated and data
that presented a Gaussian distribution were analyzed using
Student’s t-test (to compare between two groups) and one-way anal-
yses of variance (ANOVA) followed by Tukey’s test (for multiple
comparisons between more than two groups). Data that did not
present a Gaussian distribution were analyzed using the Mann–
Whitney U and Kruskal–Wallis tests. Statistical analyses were done
using GraphPad Software (La Jolla, CA). All data are representative
of at least two independent experiments performed in triplicates.
Data availability
RNA sequencing data have been deposited in NCBI’s Gene Expres-
sion Omnibus (Edgar et al, 2002) and are accessible through GEO
Series accession number GSE102463 (https://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE102463).
Expanded View for this article is available online.
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